
The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that’s the first to cut the frequency of cluster headaches. Episodic cluster headaches are “an extremely painful and often debilitating condition,” the FDA’s Dr. Eric Bastings noted in an agency news release. He’s deputy director of the Division of… read on >